Put Patients First! Take Action in ASA’s100 Days Campaign

WELCOME TO ASA’S FIRST 100 DAYS CAMPAIGN!

The first 100 days of the 47th Administration and 119th Congress will set policy priorities that impact millions of patients across America. From the economy to housing and public health, these decisions will shape the direction of medical cannabis policy for years to come. The only way to ensure these changes truly benefit patients is to make our voices heard!

THE OFFICE OF THE 47^TH PRESIDENT: 

While the Trump Administration’s 100-day plan does not explicitly include federal medical cannabis reforms, President Trump has repeatedly expressed support for medical cannabis on the campaign trail. Although the President cannot directly change cannabis laws, his administration can take several key actions to significantly improve the lives of patients without requiring legislative action from Congress.

Key priorities for the 47th POTUS include:

1. Stop evictions of medical cannabis patients in federal housing
2. Allow VA doctors to recommend cannabis
3. Stop drug testing federal employees for cannabis
4. Reinstate the Cole memo
5. Ask Congress for comprehensive medical cannabis legislation 

CONGRESS: 

The 119th Congress brings new opportunities to build on the Department of Health and Human Services (HHS) and the Department of Justice’s (DOJ) confirmation that cannabis has accepted medical use to advance a proactive agenda to secure federal rights for medical cannabis patients and create nationwide access. This Congress begins with deadlines to address several critical policy issues that directly impact medical cannabis patients, including items in budget bills that must be passed by March 14, 2025, and the reauthorization of the Farm Bill that must be passed in September.

Key priorities for the 119th Congress include:

1. Passing the CJS Medical Cannabis Amendment without clawbacks to protect patients and providers. (stop amendments from progressing in CJS Appropriations like those passed in the 118th House version).
2. Allowing the rescheduling process to proceed unimpeded (stop amendments from progression in CJS Appropriations like were passed in the 118th House version).
3. Ensuring resources are allotted to expand research under the 2022 Research Act, broadening knowledge of cannabis’ therapeutic benefits and improving access for patients.
4. Ensuring that amendments to the hemp program in the Farm Bill do not harm patient access, pairing amendments with legislation like the MCCA to enhance regulatory oversight and access.
5. Pushing back against proposals to place cannabis oversight under the FDA, advocating instead for a specialized agency like the Office of Medical Cannabis and Cannabinoid Control (OMC).
6. Supporting the Medical Cannabis and Cannabinoid Act (MCCA), a comprehensive bill being finalized by Americans for Safe Access (ASA) to restore patient federal rights and regulate the unregulated cannabinoid market.

It is not just the freshman class of the 119^th Congress, nine new Senators (four Democrats, five Republicans) and 63 new Representatives (33 Democrats, 30 Republicans), that need to hear from patient advocates; in the last session of Congress, we learned that misinformation among elected officials in Washington, D.C., has hindered progress toward national safe access. This underscores the need for proactive advocacy to educate lawmakers and ensure patient needs remain front and center.

The only way to ensure that the Administration and Congress PUT PATIENTS FIRST is if they hear from YOU!

ACT NOW TO ADVANCE A COMPASSIONATE AGENDA FOR AMERICA!

TAKE ACTION NOW!